FLG, FLG2, RPTN, HRNR and SPRR1A seem to play a key role in skin barrier dysfunction in CTCL and could be considered a biomarker for differential diagnosis of AD and CTCL. This evidence concerns the gene FLG2 and primary cutaneous T-cell non-Hodgkin lymphoma.